Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barlier

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
European Journal of Endocrinology|May 6, 2022
Multiple endocrine neoplasia type 1 caused by mosaic mutation: clinical follow-up and genetic counseling?Lucie Coppin, Sophie Giraud, Eric Pasmant, et al.
Endocrine-Related Cancer|December 17, 2015
GHRH excess and blockade in X-LAG syndromeAdrian F Daly, Philippe A Lysy, Céline Desfilles, et al.
European Journal of Endocrinology|February 12, 2025
Phenotype and genotype of 23 patients with hypopituitarism and pathogenic GLI2 variantsKarine Aouchiche, Camille Charmensat, Pertuit Morgane, et al.
American Journal of Human Genetics|September 25, 2025
Unraveling the impact of VHL exon 2 mutations in erythrocytosis or von Hippel-Lindau disease identified RNA-binding proteins involved in VHL splicingValéna Karaghiannis, Loïc Schmitt, Franck Chesnel, et al.
Molecular Biomedicine|April 2, 2026
Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomasVíctor García-Vioque, Sergio Pedraza-Arevalo, María Trinidad Moreno-Montilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM TrialThomas Graillon, Marc Sanson, Chantal Campello, et al.
Journal of Medical Genetics|August 28, 2021
International initiative for a curated <i>SDHB</i> variant database improving the diagnosis of hereditary paraganglioma and pheochromocytomaLaurene Ben Aim, Eamonn R Maher, Alberto Cascon, et al.
Endocrine-Related Cancer|August 14, 2013
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutationsMarie-Lise Jaffrain-Rea, Sandra Rotondi, Annarita Turchi, et al.
European Journal of Endocrinology|July 13, 2016
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP networkSusanne Thiele, Giovanna Mantovani, Anne Barlier, et al.
Clinical Endocrinology|October 24, 2020
Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohortNicolas Jullien, Alexandru Saveanu, Julia Vergier, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
European Journal of Endocrinology|May 6, 2022
Multiple endocrine neoplasia type 1 caused by mosaic mutation: clinical follow-up and genetic counseling?Lucie Coppin, Sophie Giraud, Eric Pasmant, et al.
Endocrine-Related Cancer|December 17, 2015
GHRH excess and blockade in X-LAG syndromeAdrian F Daly, Philippe A Lysy, Céline Desfilles, et al.
European Journal of Endocrinology|February 12, 2025
Phenotype and genotype of 23 patients with hypopituitarism and pathogenic GLI2 variantsKarine Aouchiche, Camille Charmensat, Pertuit Morgane, et al.
American Journal of Human Genetics|September 25, 2025
Unraveling the impact of VHL exon 2 mutations in erythrocytosis or von Hippel-Lindau disease identified RNA-binding proteins involved in VHL splicingValéna Karaghiannis, Loïc Schmitt, Franck Chesnel, et al.
Molecular Biomedicine|April 2, 2026
Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomasVíctor García-Vioque, Sergio Pedraza-Arevalo, María Trinidad Moreno-Montilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM TrialThomas Graillon, Marc Sanson, Chantal Campello, et al.
Journal of Medical Genetics|August 28, 2021
International initiative for a curated <i>SDHB</i> variant database improving the diagnosis of hereditary paraganglioma and pheochromocytomaLaurene Ben Aim, Eamonn R Maher, Alberto Cascon, et al.
Endocrine-Related Cancer|August 14, 2013
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutationsMarie-Lise Jaffrain-Rea, Sandra Rotondi, Annarita Turchi, et al.
European Journal of Endocrinology|July 13, 2016
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP networkSusanne Thiele, Giovanna Mantovani, Anne Barlier, et al.
Clinical Endocrinology|October 24, 2020
Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohortNicolas Jullien, Alexandru Saveanu, Julia Vergier, et al.
Pageof 17